TCL Archive As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move September 13, 2002Vol.28 No.33
TCL Archive ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard September 13, 2002Vol.28 No.33
TCL Archive NCI Program Develops Bioinformatics Tool To Design Cancer Drugs September 13, 2002Vol.28 No.33
TCL Archive Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says September 06, 2002Vol.28 No.32
TCL Archive Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds September 06, 2002Vol.28 No.32
TCL Archive Mass. Requires Coverage of Routine Patient Care In Clinical Trials September 06, 2002Vol.28 No.32
